[EN] HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES [FR] INHIBITEURS DE BIOSYNTHÈSE D'HÉPARANE SULFATE POUR TRAITER DES MALADIES
Cyanopyrrole-phenyl progesterone receptor modulators and uses thereof
申请人:McComas Cameron Casey
公开号:US20070027125A1
公开(公告)日:2007-02-01
Progesterone receptor modulators of formula I, or a pharmaceutically acceptable salt thereof,
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, and R
7
are as defined herein. These compounds are useful for contraception and hormone replacement therapy. Also provided are products containing these compounds.
A case of chain propagation: α-aminoalkyl radicals as initiators for aryl radical chemistry
作者:Timothée Constantin、Fabio Juliá、Nadeem S. Sheikh、Daniele Leonori
DOI:10.1039/d0sc04387g
日期:——
The generation of aryl radicals from the corresponding halides by redox chemistry is generally considered a difficult task due to their highly negative reduction potentials. Here we demonstrate that α-aminoalkyl radicals can be used as both initiators and chain-carriers for the radical coupling of aryl halides with pyrrole derivatives, a transformation often employed to evaluate new highly reducing
Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof
申请人:McComas Cameron Casey
公开号:US20080064673A1
公开(公告)日:2008-03-13
Progesterone receptor modulators of formula I, or a pharmaceutically acceptable salt thereof,
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined herein. These compounds are useful for contraception and hormone replacement therapy. Also provided are products containing these compounds.
Palladium-Catalysed Direct Arylation of Heteroaromatics Using Unprotected Iodoanilines with Inhibition of the Amination Reaction
作者:Hamed Ammar、Henri Doucet、Anissa Beladhria、Kassem Beydoun、Ridha Salem
DOI:10.1055/s-0031-1291124
日期:2012.7
The palladium-catalysed direct arylation of heteroaromatics with unprotected iodoanilines proceeds in moderate to high yields using only 1 mol% Pd(OAc)(2) as the catalyst and potassium acetate as the base. No amination reaction was observed under these conditions. A wide variety of heteroarenes have been successfully employed.
HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
申请人:BioMarin Pharmaceutical Inc.
公开号:US20190151312A1
公开(公告)日:2019-05-23
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.